Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. (Q44015315)
Jump to navigation
Jump to search
scientific article published in July 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. |
scientific article published in July 1998 |
Statements
1 reference
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. (English)
1 reference
Lederman MM
1 reference
Connick E
1 reference
Landay A
1 reference
Kuritzkes DR
1 reference
Spritzler J
1 reference
St Clair M
1 reference
Kotzin BL
1 reference
Fox L
1 reference
Chiozzi MH
1 reference
Leonard JM
1 reference
Rousseau F
1 reference
Wade M
1 reference
Roe JD
1 reference
Martinez A
1 reference
Kessler H
1 reference
1 July 1998
1 reference
1 reference
Identifiers
1 reference